Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism
Abstract Background N6‐methyladenosine (m6A) is of great importance in renal physiology and disease progression, but its function and mechanism in renal fibrosis remain to be comprehensively and extensively explored. Hence, this study will explore the function and potential mechanism of critical reg...
Main Authors: | Wei‐Jian Ni, Hong Zhou, Hao Lu, Nan‐Nan Ma, Bing‐Bing Hou, Wei Li, Fan‐Xu Kong, Ju‐Tao Yu, Rui Hou, Juan Jin, Jia‐Gen Wen, Tao Zhang, Xiao‐Ming Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.1359 |
Similar Items
-
The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms
by: Yuxiang Zhang, et al.
Published: (2023-03-01) -
Methyltransferase-like 3-mediated N6-methyladenosine methylation modification regulates the biological activity of vascular endothelial cells via the Notch pathway
by: Yun Tang, et al.
Published: (2023-05-01) -
m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation
by: Zhanghui Yue, et al.
Published: (2022-01-01) -
IGF2BP2 Drives Cell Cycle Progression in Triple‐Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A‐Modified CDK6 Translation Initiation Process
by: Tian Xia, et al.
Published: (2024-01-01) -
Alteration of m6A epitranscriptomic tagging of ribonucleic acids after spinal cord injury in mice
by: Shuangfei Ni, et al.
Published: (2022-08-01)